Stay updated on Dostarlimab Combo in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dostarlimab Combo in Endometrial Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision displayed in the footer changed from v3.8.0 to v3.8.1, with the study record content remaining unchanged.
    Difference
    0.0%
    Check dated 2026-11-18T01:48:27.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The clinical trial record for the RUBY study is displayed, including its design, eligibility criteria, participating locations, outcomes, and data-sharing details.
    Difference
    100%
    Check dated 2026-11-10T23:31:27.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer now identifies the page as revision v3.8.0 instead of v3.7.2; the page content remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:09:59.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    An NIH-wide banner about website terminology changes appeared, and the site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:36:29.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.1 instead of v3.7.0; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T22:31:00.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page instead of the study record content. The new page includes a 403 heading and a Home link, indicating access is blocked.
    Difference
    0.5%
    Check dated 2026-09-29T22:47:57.000Z thumbnail image

Stay in the know with updates to Dostarlimab Combo in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dostarlimab Combo in Endometrial Cancer Clinical Trial page.